A new dawn for monoclonal antibodies against antimicrobial resistant bacteria

Antimicrobial resistance (AMR) is a quickly advancing threat for human health worldwide and almost 5 million deaths are already attributable to this phenomenon every year. Since antibiotics are failing to treat AMR-bacteria, new tools are needed, and human monoclonal antibodies (mAbs) can fill this...

Descripción completa

Detalles Bibliográficos
Autores principales: Troisi, Marco, Marini, Eleonora, Abbiento, Valentina, Stazzoni, Samuele, Andreano, Emanuele, Rappuoli, Rino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795047/
https://www.ncbi.nlm.nih.gov/pubmed/36590399
http://dx.doi.org/10.3389/fmicb.2022.1080059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795047/
https://www.ncbi.nlm.nih.gov/pubmed/36590399
http://dx.doi.org/10.3389/fmicb.2022.1080059

Ejemplares similares